These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10370214)

  • 1. In vitro evaluation of biodegradable epsilon-caprolactone-co-D, L-lactide/silica xerogel composites containing toremifene citrate.
    Ahola M; Rich J; Kortesuo P; Kiesvaara J; Seppälä J; Yli-Urpo A
    Int J Pharm; 1999 Apr; 181(2):181-91. PubMed ID: 10370214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the molecular weight of poly(epsilon-caprolactone-co-DL-lactide) on toremifene citrate release from copolymer/silica xerogel composites.
    Rich J; Kortesuo P; Ahola M; Yli-Urpo A; Kiesvaara J; Seppälä J
    Int J Pharm; 2001 Jan; 212(1):121-30. PubMed ID: 11165827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silica xerogel as an implantable carrier for controlled drug delivery--evaluation of drug distribution and tissue effects after implantation.
    Kortesuo P; Ahola M; Karlsson S; Kangasniemi I; Yli-Urpo A; Kiesvaara J
    Biomaterials; 2000 Jan; 21(2):193-8. PubMed ID: 10632401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silica xerogel carrier material for controlled release of toremifene citrate.
    Ahola M; Kortesuo P; Kangasniemi I; Kiesvaara J; Yli-Urpo A
    Int J Pharm; 2000 Feb; 195(1-2):219-27. PubMed ID: 10675699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro release behavior of toremifene citrate from sol-gel processed sintered silica xerogels.
    Ahola M; Kortesuo P; Kangasniemi I; Kiesvaara J; Yli-Urpo A
    Drug Dev Ind Pharm; 1999 Aug; 25(8):955-9. PubMed ID: 10434140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of sol-gel processed spray dried silica gel microspheres as carrier in controlled drug delivery.
    Kortesuo P; Ahola M; Kangas M; Kangasniemi I; Yli-Urpo A; Kiesvaara J
    Int J Pharm; 2000 May; 200(2):223-9. PubMed ID: 10867252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable polyesters for controlled release of trypanocidal drugs: in vitro and in vivo studies.
    Lemmouchi Y; Schacht E; Kageruka P; De Deken R; Diarra B; Diall O; Geerts S
    Biomaterials; 1998 Oct; 19(20):1827-37. PubMed ID: 9855183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sol-gel-processed sintered silica xerogel as a carrier in controlled drug delivery.
    Kortesuo P; Ahola M; Karlsson S; Kangasniemi I; Kiesvaara J; Yli-Urpo A
    J Biomed Mater Res; 1999 Feb; 44(2):162-7. PubMed ID: 10397917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable polymer-silica xerogel composite microspheres for controlled release of gentamicin.
    Xue JM; Tan CH; Lukito D
    J Biomed Mater Res B Appl Biomater; 2006 Aug; 78(2):417-22. PubMed ID: 16470829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of thermoset biodegradable elastomers based on star-poly(epsilon-caprolactone-co-D,L-lactide).
    Amsden B; Wang S; Wyss U
    Biomacromolecules; 2004; 5(4):1399-404. PubMed ID: 15244457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable controlled antibiotic release devices for osteomyelitis: optimization of release properties.
    Zhang X; Wyss UP; Pichora D; Goosen MF
    J Pharm Pharmacol; 1994 Sep; 46(9):718-24. PubMed ID: 7837040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinforced Mechanical Properties and Tunable Biodegradability in Nanoporous Cellulose Gels: Poly(L-lactide-co-caprolactone) Nanocomposites.
    Li K; Huang J; Gao H; Zhong Y; Cao X; Chen Y; Zhang L; Cai J
    Biomacromolecules; 2016 Apr; 17(4):1506-15. PubMed ID: 26955741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of polymer composition on rheological and degradation properties of temperature-responsive gelling systems composed of acyl-capped PCLA-PEG-PCLA.
    Petit A; Müller B; Meijboom R; Bruin P; van de Manakker F; Versluijs-Helder M; de Leede LG; Doornbos A; Landin M; Hennink WE; Vermonden T
    Biomacromolecules; 2013 Sep; 14(9):3172-82. PubMed ID: 23875877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, structure and properties of poly(L-lactide-co-ε-caprolactone) statistical copolymers.
    Fernández J; Etxeberria A; Sarasua JR
    J Mech Behav Biomed Mater; 2012 May; 9():100-12. PubMed ID: 22498288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradability and biocompatibility of a pH- and thermo-sensitive hydrogel formed from a sulfonamide-modified poly(epsilon-caprolactone-co-lactide)-poly(ethylene glycol)-poly(epsilon-caprolactone-co-lactide) block copolymer.
    Shim WS; Kim JH; Park H; Kim K; Chan Kwon I; Lee DS
    Biomaterials; 2006 Oct; 27(30):5178-85. PubMed ID: 16797693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.
    Kranz H; Ubrich N; Maincent P; Bodmeier R
    J Pharm Sci; 2000 Dec; 89(12):1558-66. PubMed ID: 11042603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipase-catalyzed biodegradation of poly(epsilon-caprolactone) blended with various polylactide-based polymers.
    Li S; Liu L; Garreau H; Vert M
    Biomacromolecules; 2003; 4(2):372-7. PubMed ID: 12625734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphology of elastic poly(L-lactide-co-epsilon-caprolactone) copolymers and in vitro and in vivo degradation behavior of their scaffolds.
    Jeong SI; Kim BS; Lee YM; Ihn KJ; Kim SH; Kim YH
    Biomacromolecules; 2004; 5(4):1303-9. PubMed ID: 15244444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro.
    Matsumoto J; Nakada Y; Sakurai K; Nakamura T; Takahashi Y
    Int J Pharm; 1999 Aug; 185(1):93-101. PubMed ID: 10425369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of Biodegradable and Elastic Poly(ε-caprolactone-co-lactide) Copolymers and Evaluation as a Localized and Sustained Drug Delivery Carrier.
    Park JH; Lee BK; Park SH; Kim MG; Lee JW; Lee HY; Lee HB; Kim JH; Kim MS
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.